Crédit Industriel et Commercial’s Tourmaline Bio TRML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-29,661
Closed -$1.42M 420
2025
Q3
$1.42M Buy
+29,661
New +$823K 0.12% 173

Crédit Industriel et Commercial's TRML Position: Q4 2025 in Review

Crédit Industriel et Commercial sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 29,661 shares — an estimated $1.42M sold.

Crédit Industriel et Commercial first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $1.42M in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

  • Crédit Industriel et Commercial reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
  • Crédit Industriel et Commercial sold 29,661 Tourmaline Bio shares in Q4 2025, an estimated $1.42M.
  • Crédit Industriel et Commercial first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
  • Crédit Industriel et Commercial's Tourmaline Bio position peaked at $1.42M in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Crédit Industriel et Commercial's 13F filing for Q4 2025, filed 3 Feb 2026.